A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets

Transfusion

Volumn 50, Issue 8, 2010, Pages 1702-1711

  Burnouf, Thierry ^a,b,c   Kuo, Ya Po ^a,b,c   Huang, Chun Ting ^a,b,c   Tseng, Yu Hung ^a,b,c   Lin, Che Tong ^a,b,c   Su, Chen Yao ^a,b,c  

^a HUMAN PROTEIN PROCESS SCIENCES   (France)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DETERGENT; EPIDERMAL GROWTH FACTOR; FIBRINOGEN; GROWTH FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OCTOXINOL; OIL; PHOSPHATE BUFFERED SALINE; PLATELET DERIVED GROWTH FACTOR; SEPHAROSE; SOLVENT; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA1; TRIBUTYL PHOSPHATE; TRITON X 45; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL GROWTH; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; EXTRACTION; HUMAN; HUMAN CELL; NONHUMAN; PH MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; THROMBOCYTE; CELL CULTURE; CHEMISTRY; CHROMATOGRAPHY; ISOLATION AND PURIFICATION; THROMBOCYTE COUNT;

BLOOD PLATELETS; CELLS, CULTURED; CHROMATOGRAPHY; HUMANS; PLATELET COUNT; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955125203     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02646.x     Document Type: Article

References (53)

1. Maguire PB, Fitzgerald DJ. Platelet proteomics. J Thromb Haemost 2003 1 : 1593 601.
2. Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009 23 : 177 89.
3. Borzini P, Mazzucco L. Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point? ISBT Sci Ser 2007 2 : 272 81.
4. Borzini P, Mazzucco L. Platelet gels and releasates. Curr Opin Hematol 2005 12 : 473 9.
5. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997 55 : 1294 9.
6. Oyama T, Nishimoto S, Tsugawa T, Shimizu F. Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 2004 62 : 555 8.
7. Green DM, Klink B. Platelet gel as an intraoperatively procured platelet-based alternative to fibrin glue. Plast Reconstr Surg 1998 101 : 1161 2.
8. Velich N, Nemeth Z, Hrabak K, Suba Z, Szabó G. Repair of bony defect with combination biomaterials. J Craniofac Surg 2004 15 : 11 5.
9. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004 44 : 1013 8.
10. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002 18 : 27 33.
11. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004 91 : 4 15. (Pubitemid 38111215)
12. Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, Micò C, Rambaldi A, Golay J, Introna M. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 2007 40 : 785 91.
13. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005 205 : 228 36.
14. Drengk A, Zapf A, Stürmer EK, Stürmer KM, Frosch KH. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009 189 : 317 26.
15. Kazemnejad S, Allameh A, Gharehbaghian A, Soleimani M, Amirizadeh N, Jazayeri M. Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone-marrow-derived mesenchymal stem cells to functional hepatocyte-like cells. Vox Sang 2008 95 : 149 58.
16. Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007 25 : 1270 8.
17. Salvade A, Della Mina P, Gaddi D, Gatto F, Villa A, Bigoni M, Perseghin P, Serafini M, Zatti G, Biondi A, Biagi E. Characterization of platelet lysate (PL)-cultured mesenchymal stromal cells (MSC) and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 2009 May 26. [Epub ahead of print K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007 47 : 1436 46.
18. Vogel JP, Szalay K, Geiger F, Kramer M, Richter W, Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 2006 17 : 462 9. (Pubitemid 44665569)
19. Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2008 2 : 472 81.
20. Mirabet V, Solves P, Minana MD, Encabo A, Carbonell-Uberos F, Blanquer A, Roig R. Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 2008 9 : 1 10.
21. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999 79 : 1283 316.
22. Graves DT, Valentin-Opran A, Delgado R, Valente AJ, Mundy G, Piche J. The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells. Connect Tissue Res 1989 23 : 209 18.
23. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008 22 : 1276 312.
24. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008 16 : 585 601.
25. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999 7 : 335 46.
26. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 2006 117 : 143S 9S discussion 50S-51S.
27. Robson MC, Phillips LG, Thomason A, Altrock BW, Pence PC, Heggers JP, Johnston AF, McHugh TP, Anthony MS, Robson LE, Odom LL, Yanagihara D, Pierce GF. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg 1992 29 : 193 201.
28. Pierce GF, Tarpley JE, Allman RM, Goode PS, Serdar CM, Morris B, Mustoe TA, Vande Berg J. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol 1994 145 : 1399 410.
29. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000 16 Suppl 1 : S51 4.
30. Perry BH, Sampson AR, Schwab BH, Karim MR, Smiell JM. A meta-analytic approach to an integrated summary of efficacy: a case study of becaplermin gel. Control Clin Trials 2002 23 : 389 408.
31. Enestvedt CK, Hosack L, Winn SR, Diggs BS, Uchida B, O'Rourke RW, Jobe BA. VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model. J Gastrointest Surg 2008 12 : 1762 70 discussion 71-2.
32. Ferraro B, Cruz YL, Coppola D, Heller R. Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 2009 17 : 651 7.
33. Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006 24 : 227 34.
34. Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 2007 11 : 1012 30.
35. Wafai R, Tudor EM, Angus JA, Wright CE. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia. J Vasc Res 2009 46 : 45 54.
36. Kaya D, Gursoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T. VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab 2005 25 : 1111 8.
37. Han MK, Kim M, Bae SY, Kang L, Han SY, Lee YS, Rha JH, Kim SU, Roh JK. VEGF protects human cerebral hybrid neurons from in vitro ischemia. Neuroreport 2004 15 : 847 50.
38. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003 111 : 1843 51.
39. Ilzecka J. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis? Curr Opin Investig Drugs 2006 7 : 54 9.
40. Anghel A, Mut-Vitcu B, Savu L, Marian C, Seclaman E, Iman R, Neghina AM, Dragulescu SI. Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia. Genomic Med 2007 1 : 47 55.
41. Burnouf T, Tseng YH, Kuo YP, Su CY. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 2008 48 : 1090 8.
42. Su CY, Kuo YP, Lin YC, Huang CT, Tseng YH, Burnouf T. A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sang 2009 97 : 119 28.
43. Shih DT, Liao P, Kuo YP, Burnouf T, Su CY. Functional evaluation of a virally-inactivated human platelet growth factor fraction (Gf-18-f) for the expansion of human mesenchymal stem/stromal cells from adipose tissue. Transfusion 2009 49 : 22A (abstract).
44. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Transfusion 2006 46 : 2100 8.
45. Su CY, Kuo YP, Lin YC, Huang CT, Tseng YH, Burnouf T. A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sang 2009 97 : 119 28.
46. Su CY, Kuo JP, Nieh KL, Tseng YH, Burnouf T. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008 48 : 2414 20.
47. Burnouf T, Goubran H, Radosevich M, El-Ekiaby M. Preparation and viral inactivation of cryoprecipitate in blood banks in resource-limited countries. ISBT Sci Ser 2007 2 : 121 8.
48. Burnouf T, Goubran HA, Radosevich M, El-Ekiaby M. Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems. Transfus Clin Biol 2008 15 : 129 34.
49. Piet MP, Chin S, Prince AM, Brotman B, Cundell AM, Horowitz B. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion 1990 30 : 591 8.
50. Dichtelmuller HO, Biesert L, Fabbrizzi F, Gajardo R, Gröner A, von Hoegen I, Jorquera JI, Kempf C, Kreil TR, Pifat D, Osheroff W, Poelsler G. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion 2009 49 : 1931 43.
51. CPMP. Guideline on plasma-derived medicinal products (draft). CPMP/BWP/269/95 rev.4. London : The European Agency for the Evaluation of Medicinal Products 2009 cited 2010 Mar 29]. Available from: http://www.ema. europa.eu/pdfs/human/bwp/026995endraft.pdf
52. Burnouf T, Radosevich M. Nanofiltration of plasma-derived biopharmaceutical products. Haemophilia 2003 9 : 24 37.
53. Burnouf T. Modern plasma fractionation. Transfus Med Rev 2007 21 : 101 17.